For US residents only.

Financial Resources

KISQALI

Financial Resources Financial Resources

We’re committed to making treatment with KISQALI® (ribociclib) as affordable as possible. Read below to learn about ways you may be able to save on your KISQALI prescription, and then see how a KISQALI Care Patient Navigator can help simplify this process for you.

KISQALI Free Treatment Programicon-cycle

1 FREE Treatment Cycle of KISQALI and/or FEMARA

Patients are eligible to receive a 1-treatment cycle supply of any one of the following at no cost.*

a. KISQALI® (ribociclib)
b. FEMARA® (letrozole)
c. letrozole
d. KISQALI + FEMARA
e. KISQALI + letrozole
f. KISQALI FEMARA Co-Pack

Call 1-800-282-7630 or visit www.FreeTreatmentVoucher.com to receive your free treatment voucher. 

*No purchase required of the KISQALI FEMARA Co-Pack, or KISQALI or FEMARA (including generic letrozole). This offer is available for patients with a valid prescription for the KISQALI FEMARA Co-Pack, or for KISQALI and/or FEMARA (including generic letrozole), including for patients who have not been prescribed KISQALI or another Novartis product.

icon-calendarKISQALI 5-Treatment Cycle Access Program

 

Patients with commercial insurance who are still waiting for their coverage to take effect for the KISQALI FEMARA Co-Pack or KISQALI may be eligible for an additional supply of KISQALI that could continue for up to 5 treatment cycles.

For more information, talk to your doctor or call 1-800-282-7630 to speak to one of our KISQALI Care Patient Navigators.

Limitations apply. Eligible patients must have commercial insurance, a completed Service Request Form, and be experiencing a delay in obtaining coverage for KISQALI. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, Tricare, or any other federal or state program. No purchase necessary. Participation is not a guarantee of insurance coverage. Once coverage is approved, patients will no longer be eligible. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.

Universal Co-Pay Offericon-zero-copay

KISQALI and/or FEMARA $0 Co-Pay

 

You may be eligible for immediate co-pay savings on your next KISQALI FEMARA Co-Pack, KISQALI and/or FEMARA (including generic letrozole) prescriptions:

  • Commercially insured patients pay $0 per month
  • Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product
  • This offer is available for patients with a valid prescription for the KISQALI FEMARA Co-Pack, or for KISQALI and/or FEMARA (including generic letrozole), including for patients who have not been prescribed KISQALI or another Novartis product

Limitations apply. Patient must have commercial insurance. Offer is not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full terms and conditions, visit www.CoPay.NovartisOncology.com or call 1-877-577-7756.

See if you are eligible for the Universal Co-Pay Program at www.CoPay.NovartisOncology.com, or call 1-877-577-7756.

KISQALI and FEMARA Co-Pay OfferKISQALI Co-Pay Offer

icon-government

Government-Insured Patients

 

If you are covered by Medicaid, Medicare, or any other federal or state insurance program, your KISQALI Care Patient Navigator can help you understand your drug coverage and provide information about resources that may be able to provide financial assistance.

For information, call 1-800-282-7630.

KISQALI Care is brought to you by Novartis Patient Assistance Now Oncology.Novartis Patient Assistance Now Oncology